πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 45 of 99

  1. GLPG0974

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  2. GLPG1205

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  3. GLPG1205 50mg q.d.

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  4. GLPG1205 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  5. GLPG1205 single ascending doses, oral suspension

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  6. GLPG1690

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  7. GLPG1690 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  8. GLPG1690 single ascending doses

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  9. GLPG1837 500 mg

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  10. GLPG1837 single ascending doses

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  11. GLPG1972

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  12. GLPG1972 - A

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  13. GLPG1972 600 mg oral solution fasted

    Lakefront Biotherapeutics NV

    Osteoarthritis

    phase 1 small molecule completed

    1 trial

  14. GLPG1972 cohort 1

    Lakefront Biotherapeutics NV

    Osteoarthritis

    phase 1 small molecule completed

    1 trial

  15. GLPG1972 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  16. GLPG1972 single ascending doses

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  17. GLPG2222 single dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  18. GLPG2451 dose regimen A

    Lakefront Biotherapeutics NV

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  19. GLPG2451 multiple dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  20. GLPG2451 single dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  21. GLPG2737 single dose

    Lakefront Biotherapeutics NV

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  22. GLPG2737 single dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  23. GLPG3067 single dose

    Lakefront Biotherapeutics NV

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  24. GLPG3067 single dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  25. GLPG3121

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  26. GLPG3121 SAD

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  27. GLPG3312 IR

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  28. GLPG3667

    Lakefront Biotherapeutics NV

    Plaque Psoriasis

    phase 1 small molecule completed

    1 trial

  29. GLPG3667

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    3 trials

  30. GLPG3667 capsule

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  31. GLPG3667 oral suspension

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  32. GLPG3970 film-coated tablet

    Lakefront Biotherapeutics NV

    Systemic Lupus Erythematosus

    phase 1 small molecule terminated

    1 trial

  33. GLPG3970 film-coated tablet

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  34. GLPG3970 oral solution

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  35. GLPG4059 oral suspension

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule terminated

    1 trial

  36. GLPG4399 oral suspension

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  37. GLPG4716

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  38. GLS-5700

    INOVIO PHARMACEUTICALS, INC.

    Healthy

    phase 1 mab completed

    2 trials

  39. GLS-6150

    INOVIO PHARMACEUTICALS, INC.

    HCV Infection

    phase 1 mab completed

    1 trial

  40. GMCN-508B (LentiRed)

    The First People's Hospital of Lianyungang

    Transfusion Dependent Beta-Thalassemia

    phase 1 gene therapy active

    1 trial

  41. GME751

    Sandoz Pty Ltd

    Melanoma

    phase 1 small molecule active

    1 trial

  42. GMX1777

    Teva Pharma GmbH

    Solid Tumors and Lymphomas

    phase 1 small molecule terminated

    1 trial

  43. GPC3 and/or TGFΞ² targeting CAR-T cells

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  44. GPC3-CAR-T cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 mab on hold

    1 trial

  45. GPRC5D CAR-T cell intravenous infusion

    The First People's Hospital of Lianyungang

    Plasma Cell Dyscrasias

    phase 1 mab active

    1 trial

  46. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Non-Alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  47. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Melanoma

    phase 1 small molecule completed

    1 trial

  48. GRNOPC1

    Lineage Cell Therapeutics

    Spinal Cord Injury

    phase 1 mab completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources Β· All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.